BRIMICA GENUAIR and DUAKLIR GENUAIR (aclidinium/formoterol), adrenergic / anticholinergic

PULMONOLOGY - New medicinal product

Opinions on drugs - Posted on Jun 09 2016

Inclusion

BRETARIS GENUAIR and DUAKLIR GENUAIR have marketing authorisation as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
The efficacy data do not show clinical benefit provided by the aclidinium/formoterol combination versus each component as a monotherapy.
They have no impact on the long-term decline in pulmonary function.